Back to mobile site

Gilead Sciences (GILD) PT Raised to $172 at BofA Securities

October 20, 2026 4:59 AM EDT Send to a Friend
BofA Securities analyst Tazeen Ahmad raised the price target on Gilead Sciences (NASDAQ: GILD) to $172.00 (from $168.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login